Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline

Maria Fleseriu, Ibrahim A. Hashim, Niki Karavitaki, Shlomo Melmed, Mohammad H Murad, Roberto Salvatori, Mary H. Samuels

Research output: Contribution to journalReview article

114 Citations (Scopus)

Abstract

Objective: To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. Participants: The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology co-sponsored this guideline. Evidence: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned two systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Conclusions: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacement or under-replacement, and managing hypopituitarism during pregnancy, pituitary surgery, and other types of surgeries. (J Clin Endocrinol Metab 101: 3888-3921, 2016).

Original languageEnglish (US)
Pages (from-to)3888-3921
Number of pages34
JournalJournal of Clinical Endocrinology and Metabolism
Volume101
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Hypopituitarism
Practice Guidelines
Surgery
Advisory Committees
Guidelines
Teleconferencing
Consensus
Committee Membership
Group Processes
Communication
Postal Service
Morbidity
Pregnancy
Therapeutics

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Hormonal replacement in hypopituitarism in adults : An endocrine society clinical practice guideline. / Fleseriu, Maria; Hashim, Ibrahim A.; Karavitaki, Niki; Melmed, Shlomo; Murad, Mohammad H; Salvatori, Roberto; Samuels, Mary H.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 101, No. 11, 01.11.2016, p. 3888-3921.

Research output: Contribution to journalReview article

Fleseriu, Maria ; Hashim, Ibrahim A. ; Karavitaki, Niki ; Melmed, Shlomo ; Murad, Mohammad H ; Salvatori, Roberto ; Samuels, Mary H. / Hormonal replacement in hypopituitarism in adults : An endocrine society clinical practice guideline. In: Journal of Clinical Endocrinology and Metabolism. 2016 ; Vol. 101, No. 11. pp. 3888-3921.
@article{d0c65b6c97334972a6fd875bcbd81322,
title = "Hormonal replacement in hypopituitarism in adults: An endocrine society clinical practice guideline",
abstract = "Objective: To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. Participants: The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology co-sponsored this guideline. Evidence: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned two systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Conclusions: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacement or under-replacement, and managing hypopituitarism during pregnancy, pituitary surgery, and other types of surgeries. (J Clin Endocrinol Metab 101: 3888-3921, 2016).",
author = "Maria Fleseriu and Hashim, {Ibrahim A.} and Niki Karavitaki and Shlomo Melmed and Murad, {Mohammad H} and Roberto Salvatori and Samuels, {Mary H.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1210/jc.2016-2118",
language = "English (US)",
volume = "101",
pages = "3888--3921",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Hormonal replacement in hypopituitarism in adults

T2 - An endocrine society clinical practice guideline

AU - Fleseriu, Maria

AU - Hashim, Ibrahim A.

AU - Karavitaki, Niki

AU - Melmed, Shlomo

AU - Murad, Mohammad H

AU - Salvatori, Roberto

AU - Samuels, Mary H.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Objective: To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. Participants: The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology co-sponsored this guideline. Evidence: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned two systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Conclusions: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacement or under-replacement, and managing hypopituitarism during pregnancy, pituitary surgery, and other types of surgeries. (J Clin Endocrinol Metab 101: 3888-3921, 2016).

AB - Objective: To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. Participants: The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology co-sponsored this guideline. Evidence: The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned two systematic reviews and used the best available evidence from other published systematic reviews and individual studies. Consensus Process: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the Pituitary Society, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Conclusions: Using an evidence-based approach, this guideline addresses important clinical issues regarding the evaluation and management of hypopituitarism in adults, including appropriate biochemical assessments, specific therapeutic decisions to decrease the risk of co-morbidities due to hormonal over-replacement or under-replacement, and managing hypopituitarism during pregnancy, pituitary surgery, and other types of surgeries. (J Clin Endocrinol Metab 101: 3888-3921, 2016).

UR - http://www.scopus.com/inward/record.url?scp=84994893397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994893397&partnerID=8YFLogxK

U2 - 10.1210/jc.2016-2118

DO - 10.1210/jc.2016-2118

M3 - Review article

C2 - 27736313

AN - SCOPUS:84994893397

VL - 101

SP - 3888

EP - 3921

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -